Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2024 Financial Results
Covalon Technologies (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has announced it will release its Q3 Fiscal 2024 financial results on Wednesday, August 21, 2024, before markets open. The company will hold a conference call and webcast to discuss these results on the same day at 8:30am ET.
Participants can join the webcast or dial in to the conference call using the provided links and numbers. The call will include a Q&A session where participants can ask questions to Company management. A recording of the call will be available on Covalon's website under the Investors tab. Financial statements and MD&A can be accessed on SEDAR PLUS and the company's website.
Covalon Technologies (TSXV: COV; OTCQX: CVALF), un'azienda avanzata nel settore delle tecnologie mediche, ha annunciato che pubblicherà i risultati finanziari del terzo trimestre dell'anno fiscale 2024 il mercoledì 21 agosto 2024, prima dell'apertura dei mercati. L'azienda terrà una conferenza telefonica e una webcast per discutere di questi risultati lo stesso giorno alle 8:30 ET.
I partecipanti possono unirsi alla webcast o chiamare la conferenza utilizzando i link e i numeri forniti. La chiamata includerà una sessione di domande e risposte in cui i partecipanti potranno porre domande alla direzione dell'azienda. Una registrazione della chiamata sarà disponibile sul sito web di Covalon nella sezione Investitori. I bilanci finanziari e il MD&A possono essere consultati su SEDAR PLUS e sul sito web dell'azienda.
Covalon Technologies (TSXV: COV; OTCQX: CVALF), una empresa avanzada en tecnologías médicas, ha anunciado que publicará sus resultados financieros del tercer trimestre del año fiscal 2024 el miércoles 21 de agosto de 2024, antes de la apertura de los mercados. La empresa realizará una conferencia telefónica y un webcast para discutir estos resultados el mismo día a las 8:30 am ET.
Los participantes pueden unirse al webcast o marcar para la conferencia utilizando los enlaces y números proporcionados. La llamada incluirá una sesión de preguntas y respuestas donde los participantes podrán preguntar a la dirección de la empresa. Una grabación de la llamada estará disponible en el sitio web de Covalon bajo la pestaña de Inversores. Los estados financieros y el MD&A se pueden acceder en SEDAR PLUS y en el sitio web de la empresa.
코발론 기술(Covalon Technologies, TSXV: COV; OTCQX: CVALF)은 첨단 의료 기술 회사로, 2024회계연도 3분기 재무 결과를 2024년 8월 21일 수요일 시장 개장 전에 발표할 것이라고 발표했습니다. 회사는 같은 날 동부 표준시 8:30에 이러한 결과를 논의하기 위해 전화 회의 및 웹캐스트를 개최할 예정입니다.
참가자는 제공된 링크와 번호를 사용하여 웹캐스트에 참여하거나 전화 회의에 접속할 수 있습니다. 이 통화는 참가자가 회사 경영진에게 질문할 수 있는 질의응답 세션을 포함할 것입니다. 통화 녹음은 코발론의 웹사이트 투자자 탭에서 이용할 수 있습니다. 재무 제표 및 MD&A는 SEDAR PLUS와 회사 웹사이트에서 확인할 수 있습니다.
Covalon Technologies (TSXV: COV; OTCQX: CVALF), une entreprise de technologies médicales avancées, a annoncé qu'elle publiera ses résultats financiers du troisième trimestre de l'exercice 2024 le mercredi 21 août 2024, avant l'ouverture des marchés. L'entreprise tiendra une conférence téléphonique et un webinaire pour discuter de ces résultats le même jour à 8h30 ET.
Les participants peuvent rejoindre le webinaire ou se connecter à la conférence téléphonique en utilisant les liens et numéros fournis. L'appel comprendra une session de questions et réponses où les participants pourront poser des questions à la direction de l'entreprise. Un enregistrement de l'appel sera disponible sur le site Web de Covalon sous l'onglet Investisseurs. Les états financiers et le MD&A peuvent être consultés sur SEDAR PLUS et le site Web de l'entreprise.
Covalon Technologies (TSXV: COV; OTCQX: CVALF), ein Unternehmen für fortschrittliche Medizintechnologien, hat angekündigt, dass es am Mittwoch, den 21. August 2024, vor Markteröffnung seine finanziellen Ergebnisse für das dritte Quartal des Geschäftsjahres 2024 veröffentlichen wird. Das Unternehmen wird am gleichen Tag um 8:30 Uhr ET eine Telefonkonferenz und einen Webcast abhalten, um diese Ergebnisse zu besprechen.
Teilnehmer können dem Webcast beitreten oder sich unter Verwendung der bereitgestellten Links und Nummern in die Telefonkonferenz einwählen. Der Anruf wird eine Q&A-Sitzung umfassen, in der Teilnehmer Fragen an das Management des Unternehmens stellen können. Eine Aufzeichnung des Anrufs wird auf der Website von Covalon unter dem Tab Investoren verfügbar sein. Finanzberichte und MD&A können über SEDAR PLUS sowie die Unternehmenswebsite abgerufen werden.
- None.
- None.
To view, listen to, and participate in the live webcast, please follow the link below:
https://events.q4inc.com/attendee/177616087
To listen and participate via the conference call, please dial:
North American Toll-Free: 1-800-549-8228
Local (
Local (
Conference ID: 69066
Participants will be able to ask questions of Company management during the Q&A portion of the conference call either by asking them on the call or by submitting them using the chat function on the webcast.
A recording of the call will be available on www.covalon.com under News & Events on the Investors tab.
Copies of Covalon’s financial statements and MD&A can be obtained on SEDAR PLUS at www.sedarplus.ca and under SEDAR Filings on the Investors tab of Covalon’s website.
Those interested in learning more about Covalon’s solutions can visit www.covalon.com or follow Covalon on LinkedIn, Facebook, or Instagram.
About Covalon
Covalon is a patient-driven medical device company, that provides innovative and cost-effective healthcare solutions for advanced wound care, infection control, and medical device coatings. Through a strong portfolio of patented technologies and solutions, we offer innovative, gentle and more compassionate options to aid patients on their healing journey. Our solutions are designed for patients and made for care providers. Covalon leverages its patented medical technology platforms and expertise in two ways: (i) by developing products that are sold under Covalon’s name; and (ii) by developing and commercializing medical products for other medical companies under development and license contracts. The Company is listed on the TSX Venture Exchange, having the symbol COV and trades on the OTCQX Market under the symbol CVALF. To learn more about Covalon, visit our website at www.covalon.com.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may contain forward-looking statements which reflect the Company's current expectations regarding future events. The forward-looking statements are often, but not always, identified by the use of words such as "seek", "anticipate", "plan, "estimate", "expect", "intend", or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might”, “will” or “will be taken”, “occur”, or “be achieved”. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts, but instead represent management’s expectations, estimates, and projections regarding future events. Forward-looking statements involve risks and uncertainties, including, but not limited to, the factors described in greater detail in the “Risks and Uncertainties” section of our management’s discussion and analysis of financial condition and results of operations for the year ended September 30, 2023, which is available on the Company’s profile at www.sedarplus.ca, any of which could cause results, performance, or achievements to differ materially from the results discussed or implied in the forward-looking statements. Investors should not place undue reliance on any forward-looking statements. The forward-looking statements contained in this news release are made as of the date of this news release, and the Company assumes no obligation to update or alter any forward-looking statements, whether as a result of new information, further events, or otherwise, except as required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240814361119/en/
To learn more about Covalon:
Investor Relations, Covalon Technologies Ltd.
Email: investors@covalon.com
Website: https://covalon.com/
Source: Covalon Technologies Ltd.
FAQ
When will Covalon Technologies (CVALF) release its Q3 Fiscal 2024 financial results?
What time is Covalon's (CVALF) Q3 Fiscal 2024 earnings conference call scheduled for?
How can investors participate in Covalon's (CVALF) Q3 Fiscal 2024 earnings call?
Where can investors find Covalon's (CVALF) financial statements and MD&A?
